Carrie D'Andrea
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Carrie D'Andrea
Grace Therapeutics, Inc. reported in an 8-K filed May 11, 2023 that Carrie D'Andrea was appointed VP Clinical Operations, effective May 8, 2023.
“On May 8, 2023, the Company appointed Carrie D'Andrea as its VP Clinical Operations, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Grace Therapeutics, Inc. (GRCE)
SEC 8-K
Current2023-05-08–present
-
Grace Therapeutics, Inc. (GRCE)
SEC 8-K
2023-05-08–2026-06-05
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Grace Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Prashant Kohli CEO, Board Member
- Robert J. DelAversano CFO, Chief Accounting Officer
- A. Brian Davis Board Member
- Donald Olds Board Member
- Edward Neugeboren Board Member
- Jan D'Alvise Board Member
- Jan D’Alvise Board Member
- Jean Marie (John) Canan Board Member
- Jean-Marie (John) Canan Board Member
- Michael L. Derby Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.